OOIR: Observatory of International Research

Papers

(The TQCC of Heart Failure Clinics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Heart Failure with Preserved Ejection Fraction	54
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	33
Unusual Forms of Pulmonary Hypertension	27
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support	26
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	26
Contents	25
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction	25
Changing Landscape of Heart Failure Imaging	22
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	21
Forthcoming Issues	21
Therapy-Related Clonal Hematopoiesis	20
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	20
When all Else Fails, Try This	19
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	19
Mitral Regurgitation	18
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	18
Preload Reduction Therapies in Heart Failure	18
Genetics of High-Altitude Pulmonary Edema	18
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	17
Contributors	16
Arrhythmias in Adult Congenital Heart Disease Heart Failure	16
Contributors	16
Contributors	15
Hypertension and Heart Failure with Preserved Ejection Fraction	15
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	14

Specific Therapy in Transthyretin Amyloid Cardiomyopathy	13
Heart Failure Clinics	13
Copyright	13
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction	12
Myocardial Dysfunction in Patients with Cancer	12
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	12
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	12
Coronary Angiography in the Evaluation of Systolic Heart Failure	11
Arrythmia-Mediated Valvular Heart Disease	10
Guide to Temporary Mechanical Support in Cardiogenic Shock	10
Contributors	10
Advanced Heart Failure in a Special Population	10
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	10
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	10
Cardiac Amyloidosis	9
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	9
Contents	9
Cardiac Contractility Modulation	9
SGLT2 Inhibitors in Heart Failure	9
Contributors	9
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	9
Application of 3D Printing Technology in Heart Failure	9
Noncoding RNAs in Pulmonary Arterial Hypertension	9
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	9
Copyright	8
Inotropes in Patients with Advanced Heart Failure	8
Preface	8
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	7
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	7
Disease-modifier Drugs in Patients with Advanced Heart Failure	7
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	7
Contents	7
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	7
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis	7
Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis	6
Copyright	6
Sleep Disorder and Heart Failure with Preserved Ejection Fraction	6
Advanced Heart Failure in Special Population	6
Contents	6
Aortic Valvular Stenosis and Heart Failure	6
Adults with Congenital Heart Disease and Transplant	6
Advanced Heart Failure: From Pathophysiology to Clinical Management	6
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	6
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	6
Contents	5
Remote Monitoring Devices and Heart Failure	5
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
Clinical Use of Biomarkers in Cardiac Amyloidosis	5
SGLT2 Inhibitors and Peripheral Vascular Events	5
Clinical Practice Guidelines in Cardio-Oncology	5

Pathophysiology of Cardiac Amyloidosis	4
Coronary Microvascular Dysfunction	4
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure	4
Contributors	4
Novel Non-pharmacological Approaches to Heart Failure	4
The Risk of Sudden Unexpected Cardiac Death in Children	4
Advances in the Therapy of Light Chain Cardiac Amyloidosis	4
Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction	4
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?	4
Contributors	4
Contributors	4
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	4
Forthcoming Issues	4
Latest Updates in Heart Failure Imaging	4